Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration
Clinical trial NCT04537884 · COMPLETED
Trial details
- NCT number
- NCT04537884
- Sponsor
- Unity Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2022-01-25
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.